🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Several professionals said the demand for the experimental drug could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking penalties, prosecution or imprisonment.

Platform Reaction and Content Removal

According to the social media company, the platform has taken down problematic material and banned related hashtags and query recommendations. The company stated it was committed to maintaining the platform secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, populated with photos of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

Within moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about body mass, medical conditions or past usage.

Item Details and Costs

Inside these communities, messages display dark colored packages with Royal Mail stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to potentially significant health risks”.